https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults-302648344.html
The FDA has approved the Wegovy pill based on a 64-week Phase 3 clinical trial. The results showed that participants who took the Wegovy pill once a day while combining it with a low-calorie diet and exercise achieved an average weight loss of 16.6%.
"Netizens are buzzing about the convenience of a pill over needles, though the high cost remains a major concern for many."
#MixedContinue Browsing
